Zobrazeno 1 - 10
of 311
pro vyhledávání: '"V. Buccheri"'
Autor:
FM Marques, V Pfister, LLM Perobelli, V Buccheri, R Santucci, GN Ribeiro, N Hamerschlak, MV Gonçalves, CS Chiattone, C Arrai-Rodrigues
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S176-S177 (2023)
Introduction: Chronic lymphocytic leukemia (CLL) exhibits diverse treatment requirements, with some patients receiving immediate treatment while others remain under observation. In 2008, the International Workshop on Chronic Lymphocytic Leukemia (IWC
Externí odkaz:
https://doaj.org/article/4508b080968547b58bbdfeb12e0306ec
Autor:
FMRA Moreira, EA Ramos, LNM Silva, LJ Otuyama, JGD Santos, TDM Pereira, V Buccheri, V Rocha, EDRP Velloso
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S438-S439 (2023)
Introdução/Objetivos: As SMD com sideroblastos em anel (SMD-SA) constituem um subgrupo característico, correspondendo a cerca de 10-15% dos casos de SMD no Brasil. Apresentam alterações genéticas homogêneas, com mutação somática do gene SF3
Externí odkaz:
https://doaj.org/article/2c61463493f94e17b456c0863b74a6b4
Autor:
FM Marques, V Pfister, LLM Perobelli, R Santucci, V Buccheri, TB Soares, A Azevedo, MV Gonçalves, CS Chiattone, C Arrais-Rodrigues
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S117-S118 (2021)
Objective: To describe the outcomes of different reasons for initiating first-line treatment in a series of patients with CLL. Methods: Retrospective observational study with all patients with CLL in the Brazilian Registry of CLL(RBCLL), that was sta
Externí odkaz:
https://doaj.org/article/abf8de7b0e87473a8565a0889ab032ff
Autor:
L Nardinelli, RR Giorgi, ARL Ruiz, AM Leal, PBF Pinotti, AMC Ferreira, EDRP Velloso, V Buccheri, V Rocha, I Bendit
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S423-S424 (2021)
Objective: Recently, a multiplex ligation-dependent probe amplification (MLPA®) has emerged as a method that is reported to be fast, sensitive, and cost-effective that can detect copy number variation. In the present study, MLPA analysis was compare
Externí odkaz:
https://doaj.org/article/6a517408c48c49e6bf4427b1cc7a82c9
Autor:
F.M. Marques, V. Pfister, R. Santucci, V.C. Molla, Y. Novis, T.M.B. Silveira, M.V. Gonçalves, V. Buccheri, C.S. Chiattone, C. Arrais-Rodrigues
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 42, Iss , Pp 103-104 (2020)
Externí odkaz:
https://doaj.org/article/da02127683b44aa58545cec798d15cb7
Autor:
V. Pfister, F.M. Marques, R. Santucci, V. Buccheri, A. Azevedo, T.M.B. Silveira, L. Fogliato, L. Perobelli, C.S. Chiattone, C. Arrais-Rodrigues
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 42, Iss , Pp 101-102 (2020)
Externí odkaz:
https://doaj.org/article/93ec9f1847724e3a8a5fac45bb385c26
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Brazilian Journal of Medical and Biological Research, Vol 48, Iss 2, Pp 178-185 (2015)
In adults with non-promyelocytic acute myeloid leukemia (AML), high-dose cytarabine consolidation therapy has been shown to influence survival in selected patients, although the appropriate doses and schemes have not been defined. We evaluated surviv
Externí odkaz:
https://doaj.org/article/ae87d3490c5d488a9689ee6b0d3820bf
Publikováno v:
Brazilian Journal of Medical and Biological Research, Vol 48, Iss 2, Pp 178-185 (2014)
In adults with non-promyelocytic acute myeloid leukemia (AML), high-dose cytarabine consolidation therapy has been shown to influence survival in selected patients, although the appropriate doses and schemes have not been defined. We evaluated surviv
Externí odkaz:
https://doaj.org/article/00203f0472b1439c8d92caf8a736c872
Autor:
L. Castelo, C. Belli, V. Buccheri, A. Perusini, A. Enrico, J. Arbelbide, W. Silva, M. Iastrebner, J. Gonzalez, P. Pereyra, T. Pereira, L. Marchi, V. Rocha, E. Velloso
Publikováno v:
Leukemia Research. 128:107165